Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
3.530
-0.170 (-4.59%)
At close: Aug 1, 2025, 4:00 PM
3.670
+0.140 (3.97%)
After-hours: Aug 1, 2025, 6:46 PM EDT
Inozyme Pharma Market Cap
Molecular Partners AG has a market cap or net worth of $125.32 million as of August 1, 2025. Its market cap has decreased by -42.43% in one year.
Market Cap
125.32M
Enterprise Value
-33.21M
1-Year Change
-42.43%
Ranking
Category
Stock Price
$3.53
Market Cap Chart
Since the IPO on February 21, 2018, Molecular Partners AG's market cap has decreased from $595.47M to $125.32M, a decrease of -78.96%. That is a compound annual growth rate of -18.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 125.32M | -24.05% |
| Dec 30, 2024 | 165.01M | 22.94% |
| Dec 29, 2023 | 134.22M | -38.09% |
| Dec 30, 2022 | 216.81M | -65.56% |
| Dec 30, 2021 | 629.47M | -8.03% |
| Dec 30, 2020 | 684.44M | 75.63% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |